Metadx's Dual Achievement: 'Super Gap Startups 1000+' & MAFRA R&D

## Metadx, a Leader in Veterinary Bio-information Analysis, on the Brink of Global Leap with Simultaneous Selection for Two Government Projects! Metadx, an innovative company in the field of veterinary bio-information analysis, recently secured its place in the microDIPS AX nurturing project, part of the Ministry of SMEs and Startups' ambitious ‘Super Gap Startup 1000+ Project,’ establishing a strong foothold for global market entry. This selection provides Metadx with a valuable opportunity to pursue explosive growth through collaboration with large corporations and global companies, and to accelerate its expansion into overseas markets. Metadx has been developing specialized solutions for veterinary bio-information analysis to innovate veterinarians' clinical environments and ultimately contribute to improving pet health. In particular, it is highly regarded for significantly enhancing diagnostic accuracy and veterinarians' decision-making convenience by standardizing and structuring vast sample data with its unique analysis technology based on Veterinary Bioinformatics, and then integrating cutting-edge machine learning algorithms. This technological capability is opening new horizons in the veterinary field by simplifying complex diagnostic processes and enabling faster and more accurate diagnoses. Furthermore, Metadx announced good news that will further strengthen its R&D momentum. It has been finally selected for a national R&D project for technology commercialization, overseen by the Ministry of Agriculture, Food and Rural Affairs, in collaboration with Green Vet, the leading company in the animal diagnostic testing industry, and MJ Biogen. With a total of 2.5 billion won in R&D funding over the next five years, Metadx will be able to accelerate the advancement of its core technologies and focus on developing leading solutions for future veterinary medicine. This is expected to be a tremendous nutrient for realizing Metadx's innovative vision. Kim Jin-wook, CEO of Metadx, expressed extraordinary aspirations regarding this double good fortune. He stated, "The global veterinary market is currently undergoing a major transformation through the combination of animal medical information and artificial intelligence. Our mission is to quickly capture the market at this critical inflection point." He emphasized, "Being simultaneously selected for two prestigious government support projects is official recognition of Metadx's technological capabilities and growth potential. Using this as a springboard, we will overwhelmingly strengthen our R&D capabilities and speed, establishing an unrivaled technological advantage in the explosively growing global veterinary medical AI market and leading the future." Metadx's successful project selection provides significant momentum for South Korea's veterinary technology to stand tall on the global stage. Based on its unique technological prowess and full government support, the future of veterinary medicine that Metadx will shape is highly anticipated.